Alt Biotech
PrivateLast Round
Grant
Sep 18, 2024
Total Funding Raised
$661,000
Company Overview
Alt Biotech operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a Grant round in September 2024.
Alt Biotech is a biotechnology company that develops an innovative bioproduction method to generate affordable, high-quality growth factors, cytokines, and hormones for cell culture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alt Biotech Comparables
Compare Alt Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bright Biotech | 87% | |
| Multus Biotechnology | 84% | |
| Core Biogenesis | 81% |
For institutional investors. Book with your work email.
Alt Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 18, 2024 | ||||
| Accelerator | Jan 25, 2024 | ||||
| Debt | Nov 2, 2023 | ||||
| Accelerator | May 23, 2023 |
For institutional investors. Book with your work email.
Alt Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotope by VIB | Accelerator |
| Ministry of Higher Education and Research | Grant |
| Genopole | Debt |
| Bpifrance | Grant |
| CDG Invest | Accelerator |
| 212 Founders | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 18, 2024
$640K grant received from Bpifrance and Ministry of Higher Education and Research.
For institutional investors. Book with your work email.
Alt Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alt Biotech's valuation, stock price, and market status.
Is Alt Biotech a public or private company?
Alt Biotech is a private company.
What is the current stock price of Alt Biotech?
Alt Biotech is a private company, so its shares have no public market price. Caplight tracks Alt Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alt Biotech worth (valuation)?
Valuation information for Alt Biotech is not publicly available.
Can I buy Alt Biotech stock?
Alt Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alt Biotech's last funding round?
Alt Biotech's most recent funding round was Grant on September 18, 2024.
Who are the main investors in Alt Biotech?
Key investors in Alt Biotech include CDG Invest.
Will Alt Biotech IPO soon?
No public IPO plans have been announced for Alt Biotech.
How can I track Alt Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Alt Biotech's shares on secondary markets.